Abstract
1 Imipramine induced significant reduction in salivary rate compared to placebo in a cross-over, double-blind study of twelve normal volunteers. In contrast, there was no significant difference between the reduction in salivary rate induced by dothiepin and placebo. 2 Comparison of salivary rates showed no significant difference between the drugs in the initial and cross-over treatment periods. However, pooled observations from the initial and cross-over treatment periods indicated that imipramine produced a significantly greater reduction in salivary rate than dothiepin. 3 The results suggest that dothiepin would cause far less dryness of mouth compared to imipramine. This feature might ensure greater therapeutic compliance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Johnson F., Sacco F. A., Yellowley T. W. Chlordiazepoxide and dothiepin compared in anxiety-depression in general practice. Practitioner. 1973 Sep;211(263):362–364. [PubMed] [Google Scholar]
- Lipsedge M. S., Rees W. L. A double-blind comparison of dothiepin and amitriptyline for the treatment of depression with anxiety. Psychopharmacologia. 1971;19(2):153–162. doi: 10.1007/BF00402639. [DOI] [PubMed] [Google Scholar]
- Sim M., Reid D., Pallett J., Gordon E. The Hamilton rating scale. An assessment bases on a dothiepin ("prothiaden") versus imipramine ("Tofranil") clinical trial. Int Pharmacopsychiatry. 1975;10(3):142–148. doi: 10.1159/000468184. [DOI] [PubMed] [Google Scholar]